- Home
- BYFC vs IOBT Comparison
BYFC vs IOBT Comparison
Compare BYFC & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BYFC
- IOBT
- Stock Information
- Founded
- BYFC 1946
- IOBT 2014
- Country
- BYFC United States
- IOBT Denmark
- Employees
- BYFC N/A
- IOBT N/A
- Industry
- BYFC Savings Institutions
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- BYFC Finance
- IOBT Health Care
- Exchange
- BYFC Nasdaq
- IOBT Nasdaq
- Market Cap
- BYFC 64.1M
- IOBT 56.7M
- IPO Year
- BYFC 1996
- IOBT 2021
- Fundamental
- Price
- BYFC $7.96
- IOBT $0.84
- Analyst Decision
- BYFC
- IOBT Strong Buy
- Analyst Count
- BYFC 0
- IOBT 3
- Target Price
- BYFC N/A
- IOBT $9.33
- AVG Volume (30 Days)
- BYFC 8.5K
- IOBT 203.5K
- Earning Date
- BYFC 10-29-2024
- IOBT 03-04-2025
- Dividend Yield
- BYFC N/A
- IOBT N/A
- EPS Growth
- BYFC N/A
- IOBT N/A
- EPS
- BYFC 0.28
- IOBT N/A
- Revenue
- BYFC $35,113,000.00
- IOBT N/A
- Revenue This Year
- BYFC N/A
- IOBT N/A
- Revenue Next Year
- BYFC N/A
- IOBT N/A
- P/E Ratio
- BYFC $27.96
- IOBT N/A
- Revenue Growth
- BYFC 12.14
- IOBT N/A
- 52 Week Low
- BYFC $4.41
- IOBT $0.66
- 52 Week High
- BYFC $9.46
- IOBT $1.89
- Technical
- Relative Strength Index (RSI)
- BYFC 57.32
- IOBT 45.71
- Support Level
- BYFC $6.99
- IOBT $0.77
- Resistance Level
- BYFC $9.46
- IOBT $0.95
- Average True Range (ATR)
- BYFC 0.58
- IOBT 0.08
- MACD
- BYFC 0.14
- IOBT -0.01
- Stochastic Oscillator
- BYFC 45.08
- IOBT 22.16
About BYFC Broadway Financial Corporation
Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank's business consists of deposits from the general public and using such deposits, together with borrowings and other funds, to make mortgage loans secured by residential properties and commercial real estate. Its deposits consist of passbook savings accounts, checking accounts, and negotiable order of withdrawal accounts, money market accounts and fixed-term certificates of deposit. The revenue is derived from interest income on loans and investments.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.